FindTrial
Sign In

Value of ARFI elastography for the prediction of chemotherapeutic response in the patient with metastatic liver lesions from colorectal cancer

Value of ARFI elastography for the prediction of chemotherapeutic response in the patient with metastatic liver lesions from colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004611
Enrollment
75
Registered
2020-01-07
Start date
2018-05-09
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. having measurable liver metastasis on CT or MRI 2. having liver metastasis located within 6 cm from the skin 3. having not received chemotherapy, or having received chemotherapy at least one month ago and there was no liver metastasis at the end of treatment

Exclusion criteria

Exclusion criteria: 1. cannot hold their breath or ARFI technique is not feasible due to cardiac motion, etc. 2. large amount of ascites 3. having difficulty in communication

Design outcomes

Primary

MeasureTime frame
stiffness of liver metastasis measured by using ARFI—

Secondary

MeasureTime frame
size of liver metastasis measured on CT;progression-free survival;overall survival—

Countries

Korea, Republic of

Contacts

Public ContactJae Seok Bae

Seoul National University Hospital

baejae@snu.ac.kr+82-2-2072-3107

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026